HHAA
AGN

Henry H. Armstrong Associates’s Allergan plc AGN Stock Holding History

Henry H. Armstrong Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,690
Closed -$540K – 54
2019
Q1 		$540K Hold
3,690
– – 0.08% 40
2018
Q4 		$493K Hold
3,690
– – 0.08% 39
2018
Q3 		$703K Hold
3,690
– – 0.11% 34
2018
Q2 		$615K Hold
3,690
– – 0.1% 36
2018
Q1 		$616K Hold
3,690
– – 0.1% 36
2017
Q4 		$604K Hold
3,690
– – 0.1% 37
2017
Q3 		$756K Hold
3,690
– – 0.14% 35
2017
Q2 		$897K Buy
+3,690
New +$867K 0.17% 33

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Henry H. Armstrong Associates's AGN Position: Q2 2019 in Review

Henry H. Armstrong Associates sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 3,690 shares — an estimated $540K sold.

Henry H. Armstrong Associates first reported a position in AGN in Q2 2017 and held it in 8 quarters. The position peaked at $897K in Q2 2017. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Henry H. Armstrong Associates reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Henry H. Armstrong Associates sold 3,690 Allergan plc shares in Q2 2019, an estimated $540K.
  • Henry H. Armstrong Associates first reported a position in Allergan plc in Q2 2017 and held it in 8 quarters.
  • Henry H. Armstrong Associates's Allergan plc position peaked at $897K in Q2 2017.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Henry H. Armstrong Associates's 13F filing for Q2 2019, filed 19 Jul 2019.